
Ezydapa M 10mg/500mg Tablet ER
Marketer
Econ Healthcare Pvt Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg)
Overview Ezydapa M 10mg/500mg Tablet ER
Diabetic patients with type 2 mellitus may find relief with Ezydapa M 10mg/500mg Extended-Release Tablets, a dual-action medication. This formulation effectively manages elevated blood glucose, thereby mitigating the risk of severe diabetic complications and contributing to cardiovascular health. Administer this medication with food, consistently at the same time each day for optimal adherence. Dosage should be determined and monitored by your physician; discontinuation without medical guidance is strongly discouraged, as it could lead to dangerously elevated blood sugar, potentially causing kidney damage or vision loss. Remember, Ezydapa M is one component of a comprehensive diabetes management plan, requiring a balanced diet, regular physical activity, and weight management as directed by your doctor. Commonly reported side effects include throat irritation, nasal stuffiness, rhinorrhea, cephalalgia, nausea, emesis, and diarrhea. Adequate hydration is crucial to avoid dehydration. Genital fungal infections are a potential, albeit infrequent, adverse effect; diligent hygiene can minimize this risk. Prior to commencing treatment, individuals with hepatic or renal impairment, urinary tract infections, or those using diuretics should inform their physician. Pregnant or lactating women should seek medical counsel before using this medication. Limit alcohol consumption while on Ezydapa M, as it can intensify certain side effects. Regular blood glucose monitoring is recommended during treatment.
Primary Ingredients of Ezydapa M 10mg/500mg Tablet ER
No information provided. Please provide the text you wish me to rephrase.
Uses of Ezydapa M 10mg/500mg Tablet ER
Managing Type 2 diabetes
Major Benefits of Ezydapa M 10mg/500mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Ezydapa M 10mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Ezydapa M 10mg/500mg Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Ezydapa M 10mg/500mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Ezydapa M 10mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
How Ezydapa M 10mg/500mg Tablet ER works:
Ezydapa M 10mg/500mg Extended-Release Tablets combine dapagliflozin and metformin to manage type 2 diabetes. Dapagliflozin facilitates glucose excretion via the kidneys, while metformin reduces hepatic glucose output, slows intestinal glucose uptake, and enhances insulin responsiveness. This dual action improves glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Combining Ezydapa M 10mg/500mg Extended-Release Tablets with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Ezydapa M 10mg/500mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Ezydapa M 10mg/500mg tablet is likely not safe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Ezydapa M 10mg/500mg Extended-Release tablets cautiously. Dosage modification of Ezydapa M 10mg/500mg Extended-Release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Ezydapa M 10mg/500mg Extended-Release tablets cautiously. Dosage modification of Ezydapa M 10mg/500mg Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Ezydapa M 10mg/500mg Tablet ER :
Should you forget to take your Ezydapa M 10mg/500mg Extended-Release tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Ezydapa M 10mg/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
